List of works by Marcela V. Maus

A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes

scientific article published on December 2002

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.

scientific article published in July 2017

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

scientific article published on 25 December 2018

Abstracts of the 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)

Adoptive T-Cell Transfer: Harnessing Immune Cells to Combat Disease

scientific article published on 16 November 2015

Adoptive immunotherapy for cancer or viruses

scientific article published on 09 January 2014

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

scientific article published on 21 February 2019

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.

scientific article published on 19 April 2018

Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas

scientific article published on 08 August 2018

Biomanufacturing for clinically advanced cell therapies

scientific article published in June 2018

Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection

scientific article

CAR-T Cell Therapies From the Transfusion Medicine Perspective

scientific article published on 28 March 2016

CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity

scientific article published on 22 July 2019

CD19-Targeted CAR T Cells: A New Tool in the Fight against B Cell Malignancies

scientific article

CD8(+) T-cell responses to adeno-associated virus capsid in humans

scientific article published on 18 March 2007

CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity

scientific article published on 25 March 2022

CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

scientific article published on 14 November 2019

Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors

scientific article published on 11 May 2009

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.

scientific article published on 14 June 2013

Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources

scientific article published on 01 September 2020

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

scientific article

Chimeric Antigen Receptor T-Cells: New Approaches to Improve Their Efficacy and Reduce Toxicity

scientific article

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance

article by Michael M Boyiadzis et al published 4 December 2018 in Journal for Immunotherapy of Cancer

Chimeric antigen receptor T cell therapy: 25years in the making

scientific article

Designing CAR T cells for glioblastoma

scientific article published on June 2015

Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing

article

Engineered T cells for cancer therapy.

scientific article

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

scientific article published on 09 July 2018

Equity and diversity in academic medicine: a perspective from the JCI editors

scientific article published on 01 October 2019

Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

scientific article published on February 2002

Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cells

scientific article published on 21 April 2003

Gene editing for immune cell therapies

scientific article published on 03 June 2019

HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells

article

Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia

scientific article published on 26 January 2016

Immunotherapy for Glioblastoma: Adoptive T-cell Strategies

scientific article published on 16 November 2018

Prolactin as a Chemoattractant for Human Breast Carcinoma

scientific article published in November 1999

Publisher Correction: Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing

scientific article published on 15 June 2020

Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide

scientific article published on 01 January 2021

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

scientific article published on 01 December 2020

Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response

scientific article published on 07 May 2019

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

scientific article published on 18 July 2019

Toxicities associated with immunotherapies for hematologic malignancies

scientific article published in June 2018

Wishing on a CAR: Understanding the Scope of Intrinsic T-cell Deficits in Patients with Cancer

scientific article published on 01 April 2019

Paulina is supported by:

About Paulina

Help